Rv0684/fusA1, an Essential Gene, Is the Target of Fusidic Acid and Its Derivatives in Mycobacterium tuberculosis

被引:10
作者
Singh, Vinayak [2 ,3 ,4 ]
Dziwornu, Godwin Akpeko [1 ,2 ]
Mabhula, Amanda [1 ,2 ,3 ]
Chibale, Kelly [2 ,3 ,4 ]
机构
[1] Univ Cape Town, South African Med Res Council, Drug Discovery & Dev Res Unit, ZA-7701 Rondebosch, South Africa
[2] Univ Cape Town, Dept Chem, ZA-7701 Rondebosch, South Africa
[3] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7701 Rondebosch, South Africa
[4] Univ Cape Town, Drug Discovery & Dev Ctr H3D, South African Med Res Council, Drug Discovery & Dev Res Unit, ZA-7701 Rondebosch, South Africa
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
Tuberculosis; Mycobacterium tuberculosis; antituberculars; elongation factor G; Fusidic acid; MOLECULAR DOCKING; AMIDE DERIVATIVES; BINDING-SITE; ELONGATION; AGENTS;
D O I
10.1021/acsinfecdis.1c00195
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a major global health concern given the increase in multiple forms of drug-resistant TB. This underscores the importance of a continuous pipeline of new anti-TB agents. Drug repurposing has shown promise in expanding the therapeutic options for TB chemotherapy. Fusidic acid (FA), a natural product-derived antibiotic, is one such candidate for repurposing. The present study aimed to understand the mechanism of action of FA and its selected analogs in M. tuberculosis. By using chemical biology and genetics, we identified elongation factor G as the target of FA in M. tuberculosis. We showed essentiality of its encoding gene fusA1 in M. tuberculosis by demonstrating that the transcriptional silencing of fusA1 is bactericidal in vitro and in macrophages. Thus, this work validated a novel drug target FusA1 in M. tuberculosis.
引用
收藏
页码:2437 / 2444
页数:8
相关论文
共 29 条
[1]  
Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD
[2]   Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis [J].
DeJesus, Michael A. ;
Gerrick, Elias R. ;
Xu, Weizhen ;
Park, Sae Woong ;
Long, Jarukit E. ;
Boutte, Cara C. ;
Rubin, Eric J. ;
Schnappinger, Dirk ;
Ehrt, Sabine ;
Fortune, Sarah M. ;
Sassetti, Christopher M. ;
Ioerger, Thomas R. .
MBIO, 2017, 8 (01)
[3]   Novel antimycobacterial C-21 amide derivatives of the antibiotic fusidic acid: synthesis, pharmacological evaluation and rationalization of media-dependent activity using molecular docking studies in the binding site of human serum albumin [J].
Dziwornu, Godwin Akpeko ;
Kamunya, Stephanie ;
Ntsabo, Tando ;
Chibale, Kelly .
MEDCHEMCOMM, 2019, 10 (06) :961-969
[4]   Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor [J].
Ehrt, S ;
Guo, XZV ;
Hickey, CM ;
Ryou, M ;
Monteleone, M ;
Riley, LW ;
Schnappinger, D .
NUCLEIC ACIDS RESEARCH, 2005, 33 (02) :e21
[5]   Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agents [J].
Espinoza-Moraga, Marlene ;
Singh, Kawaljit ;
Njoroge, Mathew ;
Kaur, Gurminder ;
Okombo, John ;
De Kock, Carmen ;
Smith, Peter J. ;
Wittlin, Sergio ;
Chibale, Kelly .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (03) :658-661
[6]  
Ghajavand H, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02530-18, 10.1128/aac.02530-18]
[7]   High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism [J].
Griffin, Jennifer E. ;
Gawronski, Jeffrey D. ;
DeJesus, Michael A. ;
Ioerger, Thomas R. ;
Akerley, Brian J. ;
Sassetti, Christopher M. .
PLOS PATHOGENS, 2011, 7 (09)
[8]   Silencing essential protein secretion in Mycobacterium smegmatis by using tetracycline repressors [J].
Guo, Xinzheng V. ;
Monteleone, Mercedes ;
Klotzsche, Marcus ;
Kamionka, Annette ;
Hillen, Wolfgang ;
Braunstein, Miriam ;
Ehrt, Sabine ;
Schnappinger, Dirk .
JOURNAL OF BACTERIOLOGY, 2007, 189 (13) :4614-4623
[9]   The quest for the holy grail: new antitubercular chemical entities, targets and strategies [J].
Huszar, Stanislav ;
Chibale, Kelly ;
Singh, Vinayak .
DRUG DISCOVERY TODAY, 2020, 25 (04) :772-780
[10]   Novel roles for classical factors at the interface between translation termination and initiation [J].
Karimi, R ;
Pavlov, MY ;
Buckingham, RH ;
Ehrenberg, M .
MOLECULAR CELL, 1999, 3 (05) :601-609